Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ipsen
Related studies linked through entity extraction aliases.
Spanish Real-World Evidence Cabozantinib
- Status
- COMPLETED
- Phase
- N/A
Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA
- Status
- COMPLETED
- Phase
- N/A
Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity.
- Status
- COMPLETED
- Phase
- N/A
Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
- Status
- COMPLETED
- Phase
- N/A
Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors
- Status
- COMPLETED
- Phase
- N/A
Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A
- Status
- COMPLETED
- Phase
- N/A
Long-term Better Than Short-term ADT With Salvage RT
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study With Cabozantinib in Patients With RET Positive NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase I Trial HIPEC With Nal-irinotecan
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE3
Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort
- Status
- COMPLETED
- Phase
- N/A
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
- Status
- WITHDRAWN
- Phase
- N/A
Spasticity and Treatment Satisfaction Among Stroke Survivors
- Status
- COMPLETED
- Phase
- N/A